Connect with us

Business

NetworkNewsWire Issues Article On Lexaria Bioscience Corp (OTCMKTS:LXRP)

Published

on

Lexaria Bioscience Corp (OTCMKTS:LXRP) reported that company’s plan for this year are full of IP pursuits, R&D and expansion of potentials for hemp-based customer products. The company is investing more effort and time into potential commercial associations to utilize its patented DehydraTECH™ know-how and produce enhance corporate revenues.

The buzz

Most of Lexaria revenue in 2016 was noted from selling consumer offerings however they changed that last year to generate most of its revenue from out-licensing of technology. The management anticipate that trend of a majority of their revenue will come from technology out-licensing will continue in 2018. And they hope to complete and report several commercial licensing associations they currently have in development to grow overall corporate revenues in coming period.

As 2018 advances they anticipate to expand commercial adoption of their tech and also launch their tech for the first time to latest segments like NSAID and nicotine delivery. Stakeholders should note that these are long-range programs that will take time, money and testing to conclude. Lexaria Bioscience is always active with several short-term plans emphasized on short-term performance, and long-term plans intended to establish strong foundations for imminent growth.

It essentially takes time and often phenomenal efforts to record long-lasting value creation. It may appear the company is moving slowly however appearances might obscure otherwise widespread internal valuation driving movement.

Sometimes there are intense value enhancements that are simply clear while then sometimes it may take many quarters for those effects to get visible. Lexaria has been on its existing course for almost four years and has witnessed bad as well as good times. The company is all set, and planning and establishing for a raucous 2018. The management expect most of shareholders are still part of their community a year later from now as they prepare to assess at what they expect and hope to be another remarkable year.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of MMJReporter.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure

BRANDS

DETAILS

SCORE

PRODUCT SITES

  • Certified Organic
  • Made In U.S.A
  • Purity Promise
  • Price From $49

9.8

30% OFF Today! “30 0FF”

  • All Natural
  • Made In U.S.A
  • Lab Tested
  • Price From $69

9.7

  • All Natural
  • Made In U.S.A
  • Dissolvable Oral
  • Price From $99

9.6

  • All Natural
  • Made In U.S.A
  • Oral Mist
  • Price From $39

9.5

BRAND
DETAILS
  • All Organic
  • Made In U.S.A
  • Purity Promise
  • Price From $49
SCORE

9.8

PRODUCT SITE
BRAND
DETAILS
  • All Organic
  • Made In U.S.A
  • Lab Tested
  • Price From $69
SCORE

9.7

PRODUCT SITE VIEW PRODUCTS
BRAND
DETAILS
  • All Organic
  • Made In U.S.A
  • Dissolvable Oral
  • Price From $99
SCORE

9.6

PRODUCT SITE VIEW PRODUCTS
BRAND
DETAILS
  • All Organic
  • Made In U.S.A
  • Oral Mist
  • Price From $39
SCORE

9.5

PRODUCT SITE VIEW PRODUCTS
Advertisement

Symbol        Alert        High        Gain

 

  VBIO          $0.67       $4.10      500%

  IMLFF        $0.11       $0.57      400%

  CMXC        $0.25       $0.45      80%

  REPCF       $0.54       $0.79      48%

 

Get Your Latest Winner Delivered to Your Inbox!

FREE

For The Next 48 Hours

Advertisement
Advertisement
Advertisement
Advertisement
Advertisement